Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Calcium, Novobiocin
2. Crystallinic Acid
3. Monosodium Salt Novobiocin
4. Novobiocin
5. Novobiocin Calcium
6. Novobiocin, Monosodium Salt
7. Sodium, Novobiocin
8. Streptonivicin
1. Albamycin
2. Sodium Novobiocin
3. Cathomycin
4. Albadry
5. Novobiocin, Monosodium Salt
6. Novobiocin Monosodium Salt
7. Q9s9nq5yiy
8. 1476-53-5
9. Cathomycin Sodium
10. Chebi:31924
11. Nsc-2382
12. Vulcamycin
13. Drygard/biodry
14. Sodium Albamycin
15. Dsstox_cid_3386
16. Monosodium Novobiocin
17. Novobiocin Monosodium
18. Dsstox_rid_77008
19. Dsstox_gsid_23386
20. Cardelmycin Sodium Salt
21. Pa 93 Na Salt
22. Streptonivicin Sodium Salt
23. Inabiocin
24. Novobiocin, Sodium Deriv.
25. Albamycinsodium
26. Novobiocin Natrium
27. Albamycin Capsules
28. Novobiocina Bomaca
29. Component Of Albamycin Capsules
30. Albamycin (capsule)
31. Antibiotic From Streptomyces Spheroides
32. Novobiocin Sodium [usp]
33. Unii-q9s9nq5yiy
34. Novobiocin Sodium Salt (van)
35. U 6591
36. U-6591
37. Albamycin (tn)
38. Nsc 2382
39. Einecs 216-023-6
40. S2492_selleck
41. Ncgc00017033-01
42. Cas-1476-53-5
43. Novobiocin Sodium (jan/usp)
44. Spectrum1500444
45. Novobiocin Sodium [jan]
46. Chembl3183453
47. Dtxsid9023386
48. Hms500m22
49. Novobiocin Sodium [vandf]
50. Novobiocin Sodium [mart.]
51. Hms1920d04
52. Hms2091l04
53. Novobiocin Sodium [who-dd]
54. Tox21_110747
55. Ccg-40336
56. Akos030503807
57. Novobiocin Sodium [green Book]
58. Tox21_110747_1
59. Novobiocin Sodium [usp Impurity]
60. Ncgc00178810-03
61. Novobiocin Sodium [usp Monograph]
62. Novobiocin Sodium, Albamycin, Cathomycin
63. D01209
64. N-9100
65. Novobiocin Sodium, Meets Usp Testing Specifications
66. Q27114724
67. Novobiocin Sodium Salt, Antibiotic For Culture Media Use Only
68. 7-(4-(carbamoyloxy)tetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamido)-8-methylcoumarin Monosodium Salt
69. 7-[(2r,3r,4s,5r)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyl-tetrahydropyran-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxo-chromen-4-olate
70. Benzamide, N-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-.alpha.-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-buten-1-yl)-, Sodium Salt (1:1)
71. Benzamide, N-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-.beta.-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl-, Monosodium Salt
72. Benzamide, N-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-beta-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-, Monosodium Salt
73. Benzamide, N-(7-((3-o-(aminocarbonyl)-6-deoxy-5-c-methyl-4-o-methyl-beta-l-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl-, Monosodium Salt
74. Sodium 7-(((2r,3r,4s,5r)-4-(carbamoyloxy)-3-hydroxy-5-methoxy-6,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido)-8-methyl-2-oxo-2h-chromen-4-olate
75. Sodium;7-[(2r,3r,4s,5r)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-4-olate
Molecular Weight | 634.6 g/mol |
---|---|
Molecular Formula | C31H35N2NaO11 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 9 |
Exact Mass | 634.21385422 g/mol |
Monoisotopic Mass | 634.21385422 g/mol |
Topological Polar Surface Area | 199 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 1160 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Nucleic Acid Synthesis Inhibitors
Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Novobiocin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Novobiocin Sodium, including repackagers and relabelers. The FDA regulates Novobiocin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Novobiocin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Novobiocin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Novobiocin Sodium supplier is an individual or a company that provides Novobiocin Sodium active pharmaceutical ingredient (API) or Novobiocin Sodium finished formulations upon request. The Novobiocin Sodium suppliers may include Novobiocin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Novobiocin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Novobiocin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Novobiocin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Novobiocin Sodium DMFs exist exist since differing nations have different regulations, such as Novobiocin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Novobiocin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Novobiocin Sodium USDMF includes data on Novobiocin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Novobiocin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Novobiocin Sodium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Novobiocin Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Novobiocin Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Novobiocin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Novobiocin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Novobiocin Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Novobiocin Sodium suppliers with NDC on PharmaCompass.
Novobiocin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Novobiocin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Novobiocin Sodium GMP manufacturer or Novobiocin Sodium GMP API supplier for your needs.
A Novobiocin Sodium CoA (Certificate of Analysis) is a formal document that attests to Novobiocin Sodium's compliance with Novobiocin Sodium specifications and serves as a tool for batch-level quality control.
Novobiocin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Novobiocin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Novobiocin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Novobiocin Sodium EP), Novobiocin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Novobiocin Sodium USP).
LOOKING FOR A SUPPLIER?